Why Choose an HCM Center of Excellence?
At a Glance
Because Hypertrophic Cardiomyopathy (HCM) is a complex condition, receiving care at an HCM Center of Excellence ensures an accurate diagnosis, safer surgical outcomes, and access to new, closely monitored therapies from a highly experienced, multidisciplinary team.
While a general cardiologist is a critical part of your overall health care team, Hypertrophic Cardiomyopathy (HCM) is a complex condition that many doctors see only a few times in their entire careers. It is highly recommended to receive care at an HCM Center of Excellence because these specialized clinics offer a multidisciplinary team of experts with high-volume experience [1][2]. This specialized care translates into a precise diagnosis, significantly better surgical outcomes, and access to the latest therapies.
Getting the Right Diagnosis
Diagnosing and assessing the severity of HCM requires advanced expertise. Because the condition has many nuances, a Center of Excellence can confirm your exact diagnosis and subtype, ensuring you are on the correct path. Research shows that roughly one-third of patients given an HCM diagnostic code in community settings do not actually meet the strict clinical criteria for the disease [2].
Centers of Excellence have dedicated imaging experts who use advanced tools like cardiac MRI (Magnetic Resonance Imaging) to look at the structure of your heart in high detail [3][4]. They can also perform specific tests, such as looking for scar tissue (late gadolinium enhancement) to better predict your risk of dangerous heart rhythms [5].
A Multidisciplinary Team Under One Roof
Managing HCM is rarely a one-doctor job. An HCM Center of Excellence provides a team that works together [1][2], which typically includes:
- Imaging specialists who know exactly how to measure the thickness and function of your heart muscle [6].
- Genetic counselors and medical geneticists who can help identify if your condition is inherited, which is vital for your own risk assessment and for testing your family members [5].
- Electrophysiologists (experts in the heart’s electrical system) who help manage irregular rhythms and assess if you need a pacemaker or defibrillator [1].
- Advanced heart failure specialists who have deep expertise in medical therapies for HCM [2].
- Nurse coordinators who help you navigate the logistics of traveling, scheduling, and communicating with your local doctors [1].
This personalized approach, which combines your physical symptoms with genetic information and advanced imaging, helps effectively manage your symptoms, reduce your risk of complications like sudden cardiac arrest, and improve your overall quality of life [7].
Why Volume Matters for Surgery
Not everyone with HCM needs surgery. In fact, a primary role of a Center of Excellence is to carefully evaluate whether surgery is truly necessary for you [1]. However, if your heart muscle grows too thick and blocks blood flow, you might need a procedure such as a septal myectomy (open-heart surgery to remove a small portion of the thickened muscle) [8].
If surgery is needed, the expertise of the surgeon is one of the most important factors in its success. Studies consistently show that septal myectomy is associated with superior outcomes, including a lower risk of surgical complications and lower early mortality rates, when performed by highly experienced surgeons in high-volume, specialized centers [8][9]. At an experienced center, patients are much more likely to experience excellent relief from their symptoms and a safer recovery [10][11]. Conversely, having this surgery at a hospital that rarely performs it can increase your risk of complications [12][13].
Access to the Newest Therapies
Recently, new medications called cardiac myosin inhibitors (such as mavacamten) have been developed specifically to treat the underlying cause of obstructive HCM [14][15]. Because these powerful medications can sometimes reduce the heart’s pumping ability, they require very careful monitoring through a strict safety program called REMS (Risk Evaluation and Mitigation Strategy) [16][17]. Specialized centers are fully equipped to prescribe these medications, monitor your heart function safely, and manage the administrative requirements of these programs.
How Your Doctors Work Together
Traveling to a Center of Excellence does not mean you are abandoning your local cardiologist. Often, you will only need to travel for an initial evaluation, a second opinion, or a major procedure [2]. Many centers also offer telehealth options for follow-up visits. The specialist team will coordinate closely with your local cardiologist, who will continue to manage your day-to-day checkups and general heart health [1].
Next Steps: To find a recognized clinic near you, patient advocacy groups like the Hypertrophic Cardiomyopathy Association (HCMA) maintain directories of recognized Centers of Excellence that meet strict care criteria.
Common questions in this guide
What is an HCM Center of Excellence?
Will I have to leave my local cardiologist if I go to an HCM center?
Why is a surgeon's experience level important for a septal myectomy?
Can an HCM center help with genetic testing for my family?
Why do I need to go to a specialized center for new HCM medications?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How many HCM patients does this clinic or center manage each year?
- 2.If I require a septal myectomy, how many of these specific procedures does the surgeon perform annually?
- 3.How do you coordinate care and share records with my local cardiologist so I don't have to travel for every single appointment?
- 4.Do you have dedicated genetic counselors on staff to help test my family members?
- 5.Are you certified to prescribe and monitor newer therapies like mavacamten through the REMS program?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (17)
- 1
Cardiac pacing in patients with hypertrophic obstructive cardiomyopathy.
Tolosana JM, Trucco E
Global cardiology science & practice 2018; (2018(3)):29 doi:10.21542/gcsp.2018.29.
PMID: 30393641 - 2
Frequency of misdiagnosis in hypertrophic cardiomyopathy.
Nielsen SK, Rasmussen TB, Hey TM, et al.
European heart journal. Quality of care & clinical outcomes 2025; (11(2)):105-112 doi:10.1093/ehjqcco/qcae031.
PMID: 38664062 - 3
Cardiac magnetic resonance imaging in the evaluation of patients with hypertrophic cardiomyopathy.
Brenes JC, Doltra A, Prat S
Global cardiology science & practice 2018; (2018(3)):22 doi:10.21542/gcsp.2018.22.
PMID: 30393634 - 4
Cardiac magnetic resonance in the assessment of hypertrophic cardiomyopathy phenotypes and stages - pictorial review.
Stachera M, Przybyło P, Sznajder K, Gierlotka M
Polish journal of radiology 2021; (86()):e672-e684 doi:10.5114/pjr.2021.112310.
PMID: 35059060 - 5
The associations among genetic features, late gadolinium enhancement and prognosis in hypertrophic cardiomyopathy.
Su W, Wu H, Chen C, et al.
Frontiers in cardiovascular medicine 2025; (12()):1597405 doi:10.3389/fcvm.2025.1597405.
PMID: 40693221 - 6
Phenotypes of hypertrophic cardiomyopathy. An illustrative review of MRI findings.
Soler R, Méndez C, Rodríguez E, et al.
Insights into imaging 2018; (9(6)):1007-1020 doi:10.1007/s13244-018-0656-8.
PMID: 30350182 - 7
Current management of hypertrophic cardiomyopathy.
Sikand N, Stendahl J, Sen S, et al.
BMJ (Clinical research ed.) 2025; (389()):e077274 doi:10.1136/bmj-2023-077274.
PMID: 40425241 - 8
Surgical management of left ventricular outflow tract obstruction in a specialized hypertrophic obstructive cardiomyopathy center.
Hodges K, Rivas CG, Aguilera J, et al.
The Journal of thoracic and cardiovascular surgery 2019; (157(6)):2289-2299 doi:10.1016/j.jtcvs.2018.11.148.
PMID: 30782406 - 9
Regional Disparities in the Use of Septal Reduction Therapy and Associated Outcomes in the United States (from a Real-World Database).
Ashraf M, Jahangir A, Jan MF, Tajik AJ
The American journal of cardiology 2023; (191()):51-58 doi:10.1016/j.amjcard.2022.12.008.
PMID: 36640600 - 10
Treatment Strategies for Hypertrophic Cardiomyopathy: Surgical.
Schaff HV, Juarez-Casso FM
The American journal of cardiology 2024; (212S()):S53-S63 doi:10.1016/j.amjcard.2023.10.053.
PMID: 38368037 - 11
Single-Centre Experience of Surgical Myectomy for Hypertrophic Obstructive Cardiomyopathy.
Afanasyev AV, Bogachev-Prokophiev AV, Ovcharov MA, et al.
Heart, lung & circulation 2020; (29(6)):949-955 doi:10.1016/j.hlc.2019.07.009.
PMID: 31427226 - 12
Review on sudden death risk reduction after septal reduction therapies in hypertrophic obstructive cardiomyopathy.
Rigopoulos AG, Ali M, Abate E, et al.
Heart failure reviews 2019; (24(3)):359-366 doi:10.1007/s10741-018-09767-w.
PMID: 30617667 - 13
Volume-outcome relationship in septal myectomy for hypertrophic obstructive cardiomyopathy.
Hadaya J, Verma A, Sanaiha Y, et al.
Surgery 2023; (174(2)):166-171 doi:10.1016/j.surg.2023.04.028.
PMID: 37230867 - 14
Editorial: Hypertrophic Cardiomyopathy and Precision Medicine in Cardiovascular Disease.
Parums DV
Medical science monitor : international medical journal of experimental and clinical research 2025; (31()):e951868 doi:10.12659/MSM.951868.
PMID: 41174905 - 15
Mavacamten, a First-in-Class Cardiac Myosin Inhibitor for Obstructive Hypertrophic Cardiomyopathy.
Dalo JD, Weisman ND, White CM
The Annals of pharmacotherapy 2023; (57(4)):489-502 doi:10.1177/10600280221117812.
PMID: 35950315 - 16
Mavacamten: Real-World Experience From 22 Months of the Risk Evaluation and Mitigation Strategy (REMS) Program.
Desai MY, Seto D, Cheung M, et al.
Circulation. Heart failure 2025; (18(1)):e012441 doi:10.1161/CIRCHEARTFAILURE.124.012441.
PMID: 39523955 - 17
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Rationale for Clinically Guided Dose Titration to Optimize Individual Response.
Owens AT, Desai M, Wheeler MT, et al.
Journal of the American Heart Association 2024; (13(17)):e033767 doi:10.1161/JAHA.124.033767.
PMID: 39206723
This information about HCM Centers of Excellence is for educational purposes only. Always consult with your primary cardiologist or healthcare provider regarding specialist referrals and treatment plans for your specific condition.
Get notified when new evidence is published on Hypertrophic Cardiomyopathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.